Results 151 to 160 of about 2,224,846 (160)

Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer.

Journal of Pharmacy and Pharmacology, 2019
Yuan-qiao He, Yong Han
exaly  

Curcumin Lowers Erlotinib Resistance in Non-Small Cell Lung Carcinoma Cells With Mutated EGF Receptor

Oncology Research, 2014
Heng Zhao, Shanqun Li
exaly  

Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study

Pathology Research and Practice, 2018
Shu-Hong Wang, Peng-Fei Wu
exaly  

Characterising acquired resistance to erlotinib in non-small cell lung cancer patients

Expert Review of Respiratory Medicine, 2019
Masaoki Ito, Jillian Wilhelmina Paulina Bracht, Niki Karachaliou   +2 more
exaly  

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib

British Journal of Cancer, 2009
Godefridus J Peters, Elisa Giovannetti, C Calhau   +2 more
exaly  

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

Lung Cancer, 2015
Yoichi Nakanishi, Eiji Iwama, Daisuke Shibahara   +2 more
exaly  

Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial

Thoracic Cancer, 2016
Hu Liu, Yueyin Pan, Tai Ma
exaly  

Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer

Tumor Biology, 2016
exaly  

TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN

Biomedicine and Pharmacotherapy, 2016
Hua Shen
exaly  

CAF-secreted COL5A2 activates the PI3K/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma

Oral Diseases
Wenkai Zhou, Guo Yibo, Mingtao Chen
exaly